U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950892) titled 'Remote Sputum Collection in Cystic Fibrosis' on March 27.
Brief Summary: Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting sputum samples at home and sending them by mail may be feasible, uncertainty remains about how the collection of samples outside of clinic and delays in testing while in the mail impact infection detection. This study will compare bacterial cultures using sputum sampl...